Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
2019 Recap
As we wrap up the year, we’d like to thank everyone who supported The Sounding Board blog in 2019. The official launch took place in July and since then we have shared 47 posts.
Automation Glossary: Need-to-Know Terminology for Property & Casualty Claims Organizations and Collision Repair Facilities
Automating claims workflows have long been a central strategy for Property & Casualty (P&C) claims organizations and collision repair facilities seeking to efficiently and accurately process claims and manage repair complexity. In today’s dynamic environment, where each week seems to bring a new technology advancement, staying up-to-date on the latest automation technologies is key to understanding the future of the P&C industry.
Workers' Compensation Drug Formularies—Changes Afoot, Deadlines Loom
Many state formularies have implementation deadlines approaching in early 2020. Here's what you need to know.
Peter Rousmaniere Part 2: Trends and Advice for Comp
We’re back with the second part of our exclusive interview with Peter Rousmaniere in which he discusses how current trends will impact the future of the industry and gives us a preview of what he plans to do next after his retirement from workers’ comp. Here’s part 2.
Mitchell Diagnostics System Enhanced for FCA Secure Gateway and Turbo-Speed Scanning
Mitchell's all-makes scan tools from Bosch offer full access to FCA secure vehicle networks and dramatic speed improvements for pre- and post-scanning.
Warnings about impurities in Zantac® and blood pressure medicines
In September 2019, the U.S. Food and Drug Administration (FDA) reported the discovery of low levels of an impurity in brand, generic, and over- the-counter (OTC) versions of a popular heartburn medication, Zantac® (Ranitidine HCl) 1, prompting a flurry of manufacturer recalls, national distribution halts, and product removals from retail pharmacy shelves. Ranitidine is an H2 (Histamine-2) blocker approved as a prescription medicine for treatment and prevention of GI ulcers and gastroesophageal reflux disease (GERD). OTC versions are approved for relief of acid indigestion and sour stomach. H2 blockers (like Tagamet, Pepcid, and Zantac) act by reducing the amount of acid produced by cells lining the stomach.